Biohaven Ltd.

Biohaven expects to raise $125M in stock sale

New Haven-based Biohaven Ltd. said Tuesday it expects to raise about $125 million via the sale of common shares to Janus Henderson Investors.

Biohaven raises about $200M in public offering

After reporting a third-quarter loss and announcing cost-cutting measures, New Haven-based Biohaven Ltd. said it has raised about $200 million via an underwritten public offering of its common shares.

BioHaven posts 3Q loss, announces cost-cutting measures

Biohaven Ltd., a biopharmaceutical company based in New Haven, reported a third-quarter loss on Monday while announcing cost-cutting measures that did not include staff reductions.

🔒New Haven startup Bexorg uses donated brains to reshape drug discovery

Yale spinout Bexorg tests drugs on donated human brains using its BrainEx platform and partners with Biohaven to accelerate development of Alzheimer's and Parkinson's treatments.
- Advertisement -

Class action lawsuit accuses Biohaven of misleading investors

Biohaven Ltd., a New Haven-based bioscience firm, its chief executive officer and its chief financial officer are being sued over allegations that they misled investors about the viability of one of its therapies.
ADVERTISEMENT

Latest Stories

More Business News

Movers & Shakers

More Movers & Shakers | Submit an Announcement
ADVERTISEMENT

Thought Leadership

More Thought Leadership

Career Opportunities

Chief Financial Officer

Hoffman Auto Group
,
East Hartford, CT
$250,000.00 - $400,000.00

Project Development/Sales

Borghesi Building & Engineering, Co., Inc.
,
Torrington, CT
Base salary plus commission. Range $70,000-$170,000 per year.
More Jobs | Submit a Job
More Events | Submit an Event